← FDA Drug Approvals (Drugs@FDA)
SIROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2021-12-27
Drug application
- FDA Application #
ANDA215016- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SIROLIMUS
- Generic name
- Sirolimus
- Active ingredients
- SIROLIMUS
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TORRENT
- First approval
- 2021-12-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown